295 related articles for article (PubMed ID: 24552079)
1. We really need to talk: adapting FDA processes to rapid change.
Lykken S
Food Drug Law J; 2013; 68(4):357-99, i. PubMed ID: 24552079
[TBL] [Abstract][Full Text] [Related]
2. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
3. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
4. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
Heymann LA
Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
[No Abstract] [Full Text] [Related]
5. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
6. Unapproved drugs in the United States and the Food and Drug Administration.
Nasr A; Lauterio TJ; Davis MW
Adv Ther; 2011 Oct; 28(10):842-56. PubMed ID: 21894470
[TBL] [Abstract][Full Text] [Related]
7. Assessing supplement safety--the FDA's controversial proposal.
Cohen PA
N Engl J Med; 2012 Feb; 366(5):389-91. PubMed ID: 22276780
[No Abstract] [Full Text] [Related]
8. Science and regulation. FDA's approach to regulation of products of nanotechnology.
Hamburg MA
Science; 2012 Apr; 336(6079):299-300. PubMed ID: 22517845
[No Abstract] [Full Text] [Related]
9. How drugs are developed and approved by the FDA: current process and future directions.
Ciociola AA; Cohen LB; Kulkarni P;
Am J Gastroenterol; 2014 May; 109(5):620-3. PubMed ID: 24796999
[TBL] [Abstract][Full Text] [Related]
10. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
11. Regulation of drugs and devices: an evolution.
Merrill RA
Health Aff (Millwood); 1994; 13(3):47-69. PubMed ID: 7927161
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy.
Abraham J; Davis C
Soc Sci Med; 2005 Sep; 61(5):881-92. PubMed ID: 15955393
[TBL] [Abstract][Full Text] [Related]
13. The impact of FDA reform.
Trunzo J
Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
[TBL] [Abstract][Full Text] [Related]
14. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
Dodge T; Kaufman A
Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
[TBL] [Abstract][Full Text] [Related]
15. FDA policy on unapproved drug products: past, present, and future.
Chhabra R; Kremzner ME; Kiliany BJ
Ann Pharmacother; 2005; 39(7-8):1260-4. PubMed ID: 15956239
[TBL] [Abstract][Full Text] [Related]
16. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
Watson KT; Barash PG
Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
[TBL] [Abstract][Full Text] [Related]
17. Reflections on historical, scientific, and legal issues relevant to designing approval pathways for generic versions of recombinant protein-based therapeutics and monoclonal antibodies.
Dudzinski DM
Food Drug Law J; 2005; 60(2):143-260. PubMed ID: 16094771
[No Abstract] [Full Text] [Related]
18. FDA law enforcement: critical to product safety.
Rados C
FDA Consum; 2006; 40(1):21-7. PubMed ID: 16528823
[No Abstract] [Full Text] [Related]
19. The Safe Medical Devices Act of 1990--FDA. Notice.
Fed Regist; 1991 Apr; 56(66):14111-3. PubMed ID: 10111151
[TBL] [Abstract][Full Text] [Related]
20. The importance of GRAS to the functional food and nutraceutical industries.
Burdock GA; Carabin IG; Griffiths JC
Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]